399 related articles for article (PubMed ID: 12642598)
21. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
[TBL] [Abstract][Full Text] [Related]
22. Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.
Avila G
Cell Calcium; 2005 Feb; 37(2):121-7. PubMed ID: 15589992
[TBL] [Abstract][Full Text] [Related]
23. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
[TBL] [Abstract][Full Text] [Related]
24. Interaction between the dihydropyridine receptor Ca2+ channel beta-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling.
Cheng W; Altafaj X; Ronjat M; Coronado R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19225-30. PubMed ID: 16357209
[TBL] [Abstract][Full Text] [Related]
25. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.
Lyfenko AD; Goonasekera SA; Dirksen RT
Biochem Biophys Res Commun; 2004 Oct; 322(4):1256-66. PubMed ID: 15336973
[TBL] [Abstract][Full Text] [Related]
26. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin and FK506 reduce skeletal muscle voltage sensor expression and function.
Avila G; Dirksen RT
Cell Calcium; 2005 Jul; 38(1):35-44. PubMed ID: 15955561
[TBL] [Abstract][Full Text] [Related]
28. A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.
Lynch PJ; Tong J; Lehane M; Mallet A; Giblin L; Heffron JJ; Vaughan P; Zafra G; MacLennan DH; McCarthy TV
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4164-9. PubMed ID: 10097181
[TBL] [Abstract][Full Text] [Related]
29. Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor.
Mei Y; Xu L; Mowrey DD; Mendez Giraldez R; Wang Y; Pasek DA; Dokholyan NV; Meissner G
J Biol Chem; 2015 Jul; 290(28):17535-45. PubMed ID: 25998124
[TBL] [Abstract][Full Text] [Related]
30. Ca2+ activation of RyR1 is not necessary for the initiation of skeletal-type excitation-contraction coupling.
O'Brien JJ; Feng W; Allen PD; Chen SR; Pessah IN; Beam KG
Biophys J; 2002 May; 82(5):2428-35. PubMed ID: 11964231
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of local Ca2+ signaling between cardiac L-type Ca2+ channels and ryanodine receptors: insights into regulation by FKBP12.6.
Goonasekera SA; Chen SR; Dirksen RT
Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1476-84. PubMed ID: 16049053
[TBL] [Abstract][Full Text] [Related]
32. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.
Treves S; Jungbluth H; Muntoni F; Zorzato F
Curr Opin Pharmacol; 2008 Jun; 8(3):319-26. PubMed ID: 18313359
[TBL] [Abstract][Full Text] [Related]
33. A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity.
Ghassemi F; Vukcevic M; Xu L; Zhou H; Meissner G; Muntoni F; Jungbluth H; Zorzato F; Treves S
Cell Calcium; 2009 Feb; 45(2):192-7. PubMed ID: 19027160
[TBL] [Abstract][Full Text] [Related]
34. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.
Ducreux S; Zorzato F; Müller C; Sewry C; Muntoni F; Quinlivan R; Restagno G; Girard T; Treves S
J Biol Chem; 2004 Oct; 279(42):43838-46. PubMed ID: 15299003
[TBL] [Abstract][Full Text] [Related]
35. Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease.
Kraeva N; Zvaritch E; Rossi AE; Goonasekera SA; Zaid H; Frodis W; Kraev A; Dirksen RT; Maclennan DH; Riazi S
Neuromuscul Disord; 2013 Feb; 23(2):120-32. PubMed ID: 23183335
[TBL] [Abstract][Full Text] [Related]
36. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
Tong J; McCarthy TV; MacLennan DH
J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
[TBL] [Abstract][Full Text] [Related]
37. Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor.
Zorzato F; Yamaguchi N; Xu L; Meissner G; Müller CR; Pouliquin P; Muntoni F; Sewry C; Girard T; Treves S
Hum Mol Genet; 2003 Feb; 12(4):379-88. PubMed ID: 12566385
[TBL] [Abstract][Full Text] [Related]
38. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
Tilgen N; Zorzato F; Halliger-Keller B; Muntoni F; Sewry C; Palmucci LM; Schneider C; Hauser E; Lehmann-Horn F; Müller CR; Treves S
Hum Mol Genet; 2001 Dec; 10(25):2879-87. PubMed ID: 11741831
[TBL] [Abstract][Full Text] [Related]
39. Ryanodine receptor type 1 (RyR1) mutations C4958S and C4961S reveal excitation-coupled calcium entry (ECCE) is independent of sarcoplasmic reticulum store depletion.
Hurne AM; O'Brien JJ; Wingrove D; Cherednichenko G; Allen PD; Beam KG; Pessah IN
J Biol Chem; 2005 Nov; 280(44):36994-7004. PubMed ID: 16120606
[TBL] [Abstract][Full Text] [Related]
40. A central core disease mutation in the Ca
Chirasani VR; Xu L; Addis HG; Pasek DA; Dokholyan NV; Meissner G; Yamaguchi N
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C358-C365. PubMed ID: 31166712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
